Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2307-2310

  Talseth, Bente A ^a   Meldrum, Cliff ^b   Suchy, Janina ^c   Kurzawski, Grzegroz ^c   Lubinski, Jan ^c   Scott, Rodney J ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c International Hereditary Cancer Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA DETERMINATION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARYLAMINE N-ACETYLTRANSFERASE; BASE PAIR MISMATCH; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; GLUTATHIONE TRANSFERASE; HUMANS; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; XENOBIOTICS;

EID: 33845326134     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0040     Document Type: Article

References (25)

1. Fishel R, Lescoe MK, Rao MR, et al. The human imitator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
2. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994,368:258-61.
3. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
4. McGrath DR, Spigelman AD. Hereditary colorectal cancer: keeping it in the family - the bowel cancer story. Intern Med J 2002;32:325-30.
5. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995;25:27-65.
6. Ferraz JM, Zinzindohoue F, Lecomte T, et al. Impact of GSTT1, GSTM1, GSTP1, and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer. Int J Cancer 2004;110:183-7.
7. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF, Le Marchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994;54:3692-5.
8. Ye Z, Parry JM. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 2002;22:385-92.
9. Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 2001;22:1053-60.
10. Lee JCM, Park SK, Kim SU, et al. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett 2003;196:179-86.
11. Heinimann K, Scott RJ, Chappuis P, et al. N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res 1999;59: 3038-40.
12. He LJ, Yu YM, Qiao F, Liu JS, Sun XF, Jiang LL. Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk. World J Gastroenterol 2005; 11:4268-71.
13. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1998;7:1079-84.
14. Talseth BA, Meldrum C, Suchy J, Kurqawski G, Lubinski J, Scott RJ. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer 2006;118:2479-84.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996;107:229-33.
17. Sugawara T, Nomura E, Sagawa T, Sakuragi N, Fujimoto S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer 2003;13:785-90.
18. Brockton N, Little J, Sharp L, Cotton SC. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:846-61.
19. de Jong MM, Nolte IM, te Meerman GJ, et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002;11:1332-52.
20. Landi S, Gemignani F, Moreno V, et al. A comprehensive analysis of phase I, phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005;15:535-46.
21. Gyorffy B, Kocsis I, Vasarhelyi B. Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium. Gut 2004;53:614-5; author reply 615-6.
22. Lohmueller KE, Mauney MM, Reich D, Braverman JM. Variants associated with common disease are not unusually differentiated in frequency across populations. Am J Hum Genet 2006;78:130-6.
23. Gu J, Liang D, Wang Y, Lu C, Wu X. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res 2005;581: 97-104.
24. Frazier ML, O'Donnell FT, Kong S, et al. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res 2001;61:1269-71.
25. Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res 2004;10:5845-9.